Andere Kunden interessierten sich auch für
![Community Integrated Management of Childhood Illness, Lahj, Yemen]( "Community Integrated Management of Childhood Illness, Lahj, Yemen")
Community Integrated Management of Childhood Illness, Lahj, Yemen55,99 €![Health care quality in developing countries]( "Health care quality in developing countries")
Health care quality in developing countries44,99 €![The search for A3243G among type 2 Diabetes Mellitus patients.]( "The search for A3243G among type 2 Diabetes Mellitus patients.")
The search for A3243G among type 2 Diabetes Mellitus patients.32,99 €![Type 1 Diabetes Mellitus and Familial Mediterranean Fever]( "Type 1 Diabetes Mellitus and Familial Mediterranean Fever")
Type 1 Diabetes Mellitus and Familial Mediterranean Fever23,99 €![Growth Status of a Sample of Children with Type 1 Diabetes Mellitus]( "Growth Status of a Sample of Children with Type 1 Diabetes Mellitus")
Growth Status of a Sample of Children with Type 1 Diabetes Mellitus40,99 €![Resistin and Severity of Microangiopathy in Type II Diabetes Mellitus]( "Resistin and Severity of Microangiopathy in Type II Diabetes Mellitus")
Resistin and Severity of Microangiopathy in Type II Diabetes Mellitus46,99 €![Chronic Psychological Stress in Type 1 and Type 2 Diabetes Mellitus]( "Chronic Psychological Stress in Type 1 and Type 2 Diabetes Mellitus")
Chronic Psychological Stress in Type 1 and Type 2 Diabetes Mellitus32,99 €
This study aimed to determine the prevalence of anti-glutamic acid decarboxylase autoantibodies (GADA) and anti-insulin autoantibodies (IAA) in patients with T1D and their siblings in Yemen. Thirty-one patients, thirty-six siblings and fourteen controls were tested for GADA and IAA. Anti-glutamic acid decarboxylase autoantibodies was present in 12 out of 31 patients (38.7%), in 1 out of 36 siblings (2.77%) and non of the controls (0.0%) while, IAA was positive in 20 out of 31 (64.5%), in 3 out of 36 (8.3%) and 0/14 (0.0%) in patients, siblings and controls, respectively. There was a significant difference in the prevalence of GADA in patients versus siblings and controls (P 0.001 and 0.007) respectively. There also was a significant difference in the prevalence of IAA in patients versus siblings and controls (P 0.001 and 0.001) respecively.